Silica Health Risks
Compliance · Compliance overview
Silica health risks are the long-latency occupational disease risks associated with sustained exposure to respirable crystalline silica: silicosis, silica-related lung cancer and silica-related chronic obstructive pulmonary disease. This page is educational and workplace-risk focused — it sets out the recognised silica exposure effects and respirable silica hazards relevant to UK employers, and points to the silica monitoring, silica risk assessment and silica control work that sit alongside any occupational health route.
What 'silica health risks' refers to in occupational terms
Silica health risks, in an occupational context, refer to the recognised long-latency disease patterns associated with sustained exposure to respirable crystalline silica (RCS): silicosis (including chronic, accelerated and acute forms), silica-related lung cancer, and silica-related chronic obstructive pulmonary disease (COPD). There is also a recognised association between RCS exposure and certain autoimmune and renal conditions, with the strength of association varying by outcome.
This page is educational. It does not provide medical diagnosis, prognosis or treatment advice. Workers concerned about possible silica-related symptoms should be referred to occupational health and to the appropriate clinical route. The role of silica exposure assessment and silica air sampling is to characterise and control the workplace exposure that drives those long-term risks, not to provide a health diagnosis.
Silica lung disease — recognised exposure effects
Silicosis is the disease most directly tied to RCS exposure. Chronic silicosis typically follows years to decades of cumulative silica exposure; accelerated silicosis has been reported in workers with higher short-term exposures, including in engineered stone fabrication where the silica content of the material is high and exposures can spike during dry processing. Acute silicosis is rare and associated with very high exposures over relatively short periods.
Silica-related lung cancer is recognised as a long-latency outcome of sustained RCS exposure; the relevant mechanism is exposure-driven and consistent with the IARC classification of crystalline silica in the inhaled form. Silica-related COPD presents as chronic airflow limitation in workers with sustained RCS exposure, often in combination with smoking history. Each of these outcomes is recognised at the level of occupational health risk, not predicted for any individual worker.
- Chronic silicosis after sustained, long-term respirable silica exposure.
- Accelerated silicosis at higher short-term exposures, notably in engineered stone work.
- Silica-related lung cancer recognised as a long-latency outcome of RCS exposure.
- Silica-related chronic obstructive pulmonary disease (COPD).
- Recognised associations with certain autoimmune and renal conditions.
Workplace context for respirable silica hazards
Respirable silica hazards are dominated by a familiar set of workplaces: engineered stone fabrication, construction cutting and chasing, concrete cutting and coring, abrasive blasting, quarrying, tunnelling and refractories. The common factor is mechanical break-up of quartz-bearing material that liberates the respirable fraction of the dust generated.
Within those workplaces, the silica respiratory disease risk profile is driven by cumulative respirable silica exposure across a working life — and, for accelerated silicosis specifically, by the intensity of short-term peaks. That is why silica risk assessment and silica air sampling deliberately characterise both the routine exposure and the high-energy short-task peaks.
Silica monitoring and risk assessment — the workplace response
The workplace response to silica health risks is exposure-side: identify the silica-generating tasks, characterise the respirable crystalline silica exposure through personal silica air sampling, compare measured exposures against the silica WEL in HSE EH40, and apply the COSHH control hierarchy to reduce that exposure as far as is reasonably practicable.
Silica monitoring data feeds the silica risk assessment, which in turn feeds decisions about silica controls, RPE selection and the scope of occupational health surveillance. Health surveillance findings feed back into the silica risk assessment — for example by triggering closer review of silica controls in an area where surveillance suggests sustained exposure has been higher than the COSHH paperwork acknowledged.
Where occupational health sits in the silica picture
Silica-related health concerns — symptomatic workers, screening findings, return-to-work questions, fitness-for-task questions — should be handled through occupational health and the appropriate clinical route. Decisions about referral, investigation, diagnosis and treatment are clinical decisions and sit with qualified occupational health and medical professionals.
Workplace silica exposure assessment runs alongside that clinical route, not instead of it. Silica air sampling, silica risk assessment and silica control review provide the exposure-side evidence that informs occupational health programmes and that drives the engineering and work-pattern changes needed to reduce future silica health risk in the workforce.
When to request silica monitoring against health-risk concerns
Workplaces commission silica air sampling and silica risk assessment in response to health-risk concerns when occupational health surveillance flags possible silica-related findings, when symptomatic workers have been identified, when the silica exposure profile has not been formally characterised, when materials or tasks have changed (particularly a move into engineered stone), or when a workplace inspection or insurance audit asks for measured RCS exposure data.
It is also commissioned proactively, before health-risk concerns emerge, where a workplace recognises that sustained respirable crystalline silica exposure is intrinsic to its work and wants the silica COSHH and silica compliance position underpinned by current measurement data.
Frequently asked questions
What are the main silica health risks recognised in UK workplaces?
The recognised silica health risks in UK workplaces are silicosis (chronic, accelerated and rarely acute), silica-related lung cancer and silica-related chronic obstructive pulmonary disease (COPD). There are also recognised associations with certain autoimmune and renal conditions. These are occupational disease risks; individual diagnosis and prognosis are clinical matters for occupational health and medical professionals.
Is engineered stone fabrication a higher silica respiratory disease risk?
On the evidence, yes. Engineered (agglomerated) stone is typically much higher in crystalline silica content than natural stone, and a number of accelerated silicosis cases have been reported internationally in engineered stone fabrication. UK silica risk assessment and silica monitoring in engineered stone workshops therefore typically run at higher frequency and scrutiny than in lower-silica materials.
Does sitting below the silica WEL eliminate silica health risk?
No. The silica WEL is a regulatory ceiling against which silica exposure is judged for COSHH purposes; it is not a safe threshold below which RCS is harmless. Employers are expected to reduce silica exposure as far as is reasonably practicable, and many operate in-house action levels below the WEL to drive that further reduction.
Can a silica air sampling provider diagnose silicosis or other silica lung disease?
No. Silica air sampling and silica risk assessment characterise workplace silica exposure and the adequacy of silica controls. Diagnosis of silicosis, silica-related lung cancer or silica-related COPD is a clinical matter and should be handled through occupational health and the appropriate medical route.
What is the relationship between silica monitoring and health surveillance?
Silica monitoring characterises the workplace silica exposure that drives long-term silica health risk; health surveillance characterises early indicators of effect in exposed workers. The two are designed to inform each other — monitoring findings inform surveillance scope and frequency, and surveillance findings inform silica risk assessment and silica control review.
Related pages